{"id":"W4411100032","doi":"10.1186/s12933-025-02781-x","title":"Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes","year":2025,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"York University","funders":"Eli Lilly and Company","keywords":"Medicine; Internal medicine; Dulaglutide; Endocrinology; Diabetes mellitus; Type 2 diabetes; Glycemic; Overweight; Lipid profile; Placebo; Obesity; Glucagon-like peptide 1 receptor; Exenatide; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006865431,0.0007134735,0.002323096,0.0004602002,0.0001494674,0.00004245158,0.0002335207,0.0002618952,0.00006644224],"category_scores_gemma":[0.00009858893,0.0004391535,0.0003473757,0.00124006,0.0005056938,0.0002244229,0.00009775818,0.0002215142,0.0000125594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005837674,"about_ca_system_score_gemma":0.0004480963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003569885,"about_ca_topic_score_gemma":0.0008988712,"domain_scores_codex":[0.996057,0.0004512139,0.0005777153,0.001101816,0.0005482514,0.001264038],"domain_scores_gemma":[0.9975792,0.0001279729,0.000315553,0.001327477,0.000364507,0.0002853236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001636541,0.001974089,0.9339533,0.0002584778,0.04161435,0.00008711461,0.0003164821,0.00005451576,0.000626623,0.000008795798,0.0001475461,0.01932218],"study_design_scores_gemma":[0.03737928,0.02651988,0.8592324,0.001334301,0.02332347,0.000003674408,0.0008759706,0.0008335717,0.04409453,0.0000363649,0.005225242,0.00114134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944798,0.002115686,0.00003141824,0.0001016957,0.0001784531,0.002422185,0.00006653112,0.0001352067,0.0004689833],"genre_scores_gemma":[0.9964049,0.0003710186,0.001051283,0.000221682,0.00002856835,0.0005820083,0.0003867966,0.00009042518,0.000863347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0747209,"threshold_uncertainty_score":0.999806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01573269884666853,"score_gpt":0.2545787569961747,"score_spread":0.2388460581495061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}